The role of IL-1 gene cluster in longevity: a study in Italian population

In this study, we analysed the polymorphic variants of IL-1alpha (C-T transition at position -889), IL-1beta (C-T transition at position -511) and IL-1 receptor antagonist (Ra) (86-bp repeated sequence in intron 2) in 1131 subjects (453 females and 678 males) from Northern and Central Italy, including 134 centenarians, to evaluate whether IL-1 cluster alleles might be differently represented in people selected for longevity. In addition, IL-1Ra and IL-1beta plasma levels were quantified by ELISA in 130 randomly selected subjects. No significant differences in the genotype and allele frequency distributions were observed between young, elderly and centenarian subjects. IL-1Ra plasma levels showed an age-related increase, whereas IL-1beta plasma levels did not show any detectable age-related trend. Neither IL-1Ra nor IL-1beta plasma levels showed any relationship with genotypes of the three IL-1 genes. These results suggest that no one particular polymorphism in the IL-1 gene cluster yields an advantage for survival in the last decades of life, and that the age-related increase in plasma levels of IL-1Ra seems not to be genetically regulated but a likely safeguard mechanism to buffer the age-associated increased inflammatory state.

[1]  J. Féher,et al.  IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease , 1999, Immunogenetics.

[2]  L. Rosenwasser,et al.  Biologic activities of IL-1 and its role in human disease. , 1998, The Journal of allergy and clinical immunology.

[3]  Claudio Franceschi,et al.  Allele frequencies of +874T→A single nucleotide polymorphism at the first intron of interferon-γ gene in a group of Italian centenarians , 2002, Experimental Gerontology.

[4]  Association of interleukin‐1 gene polymorphisms with Alzheimer's disease , 2000, Annals of neurology.

[5]  R. Płoski,et al.  A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism , 1995 .

[6]  F. Pociot,et al.  Cytokine gene polymorphism in human disease: on-line databases, Supplement 1 , 2001, Genes and Immunity.

[7]  C. Polman,et al.  Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis , 1995, The Lancet.

[8]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[9]  J. Vaupel,et al.  Estimation of apolipoprotein E genotype‐specific relative mortality risks from the distribution of genotypes in centenarians and middle‐aged men: Apolipoprotein E gene is a “frailty gene,” not a “longevity gene” , 2000, Genetic epidemiology.

[10]  S. Brod.  Unregulated inflammation shortens human functional longevity , 2000, Inflammation Research.

[11]  C. Franceschi,et al.  A gender–dependent genetic predisposition to produce high levels of IL‐6 is detrimental for longevity , 2001, European journal of immunology.

[12]  E. Eriksen,et al.  Osteoporotic Fractures Are Associated with an 86‐Base Pair Repeat Polymorphism in the Interleukin‐1‐Receptor Antagonist Gene But Not with Polymorphisms in the Interleukin‐1β Gene , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  H. Cohen,et al.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.

[14]  G Semana,et al.  Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. , 1997, The American journal of gastroenterology.

[15]  N. Camp,et al.  An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. , 1998, American journal of human genetics.

[16]  Bente Klarlund Pedersen,et al.  Aging and proinflammatory cytokines , 2001, Current opinion in hematology.

[17]  A. Blakemore,et al.  Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat , 1993, Human Genetics.

[18]  Luigi Ferrucci,et al.  Serum IL‐6 Level and the Development of Disability in Older Persons , 1999, Journal of the American Geriatrics Society.

[19]  E A Thompson,et al.  A Monte Carlo method for combined segregation and linkage analysis. , 1992, American journal of human genetics.

[20]  A. Hoeft,et al.  Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. , 1999, Critical care medicine.

[21]  S. Humphries,et al.  Interleukin-6 −174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS) , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[22]  G. Duff,et al.  A Physical Map of the Region Encompassing the Human Interleukin-1α, Interleukin-1β, and Interleukin-1 Receptor Antagonist Genes , 1994 .

[23]  M. Hurme,et al.  Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. , 1998, Annals of medicine.

[24]  Association of early‐onset Alzheimer's disease with an interleukin‐1α gene polymorphism , 2000, Annals of neurology.

[25]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[26]  N. Camp,et al.  Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. , 1999, Circulation.

[27]  G. Annoni,et al.  Gene polymorphism affecting α1‐antichymotrypsin and interleukin‐1 plasma levels increases Alzheimer's disease risk , 2000, Annals of neurology.

[28]  W. Ledger,et al.  Influence of interleukin-1 receptor antagonist gene polymorphism on disease. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  W. Arend.  Interleukin-1 receptor antagonist. , 1993, Advances in immunology.

[30]  L Scola,et al.  Gender-specific association between −1082 IL-10 promoter polymorphism and longevity , 2002, Genes and Immunity.

[31]  M. Jylhä,et al.  Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-α genes in Finnish nonagenarians , 2001, Mechanisms of Ageing and Development.

[32]  T. Spector,et al.  Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. , 1998, Bone.

[33]  A. Blakemore,et al.  Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus , 1994, Human Genetics.

[34]  L. Iacoviello,et al.  Possible different involvement of interleukin-1 receptor antagonist gene polymorphism in coronary single vessel disease and myocardial infarction. , 2000, Circulation.

[35]  A. Blakemore,et al.  Single base polymorphism at −511 in the human interleukin-1β gene (IL1β) , 1992 .

[36]  F. Pociot,et al.  Cytokine gene polymorphism in human disease: on-line databases , 1999, Genes and Immunity.